PeopleBio
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PeopleBio - overview
Established
2002
Location
Seoul, -, South Korea
Primary Industry
Biotechnology
About
Established in 2002 and based in Seoul, South Korea, PeopleBio aims to help individuals approach a happier future through the early diagnosis and treatment of protein misfolding diseases. The company has been listed in South Korea. In June 2021, iMarket Korea, NAU IB Capital, and BNH Investment invested KRW 12. 999 billion in PeopleBio in a PIPE deal.
The company's main products currently include the OAß Test Automated System, is an automated machine for measuring the oligomerization levels of beta-amyloid in individuals suspected of having AD. The company is also developing MDS (multimer detection systems), including SI-MDS and 3D-MDS, for the treatment of Alzheimer's disease, diabetes and Parkinson's.
Current Investors
WOORI Venture Partners, SU&P, G.N.TECH Venture Capital
Primary Industry
Biotechnology
Sub Industries
Biotechnology
Website
www.peoplebio.net
Company Stage
Mature
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.